Literature DB >> 11296109

Management and outcome of complications after laparoscopic antireflux operations.

D Pohl1, T R Eubanks, P E Omelanczuk, C A Pellegrini.   

Abstract

HYPOTHESIS: Perioperative complications of laparoscopic antireflux operations are infrequent and treatable and do not cause permanent disability.
DESIGN: Retrospective review of all patients with laparoscopic antireflux operations for the management and outcome of all complications.
SETTING: University medical center. PATIENTS: All 538 patients who underwent operation from January 20, 1993, through December 28, 1999. MAIN OUTCOME MEASURES: Complications were defined as any major or minor deviation from the standard postoperative clinical pathway. Minor complications did not require invasive treatment and were not expected to result in permanent disability. Major complications required invasive treatment or could result in permanent disability. The frequency of complications was also stratified into those that occurred during primary antireflux procedures and those that occurred during reoperations for previously failed procedures.
RESULTS: Ninety-two complications occurred in 538 operations (17.1%). Sixty-eight patients (12.6%) experienced minor complications. Postoperative ileus was the most common complication (n = 37 [6.9%]), followed by pneumothorax (n = 13 [2.4%]) and urinary retention (n = 10 [1.9%]). Major complications were present in only 24 patients (4.5%) and occurred significantly more frequently after reoperations. Of these, dysphagia was the most frequent complication observed (n = 11 [2.0%]), followed by perforated viscus (n = 4 [0.7%]). Two patients (0.4%) died. All but 4 major complications resulted in full recovery.
CONCLUSIONS: Major complications in laparoscopic antireflux surgery are rare, their treatment is straightforward, and permanent disability is uncommon. Complications occur twice as often during reoperations, highlighting the difficulty in performing these procedures. Although primary laparoscopic antireflux operations are performed by many general surgeons routinely, reoperations should be performed by a team experienced in laparoscopic esophageal surgery.

Entities:  

Mesh:

Year:  2001        PMID: 11296109     DOI: 10.1001/archsurg.136.4.399

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  7 in total

1.  Delivery of radiofrequency energy to the gastroesophageal junction (Stretta procedure) for the treatment of gastroesophageal reflux disease.

Authors:  L Cipolletta; G Rotondano; L Dughera; A Repici; M A Bianco; C De Angelis; A M Vingiani; E Battaglia
Journal:  Surg Endosc       Date:  2005-05-03       Impact factor: 4.584

2.  High incidence of acute urinary retention associated with immediate catheter removal after laparoscopic Nissen fundoplication.

Authors:  Ellie Mentler; Kevan Mann; Angela Earley; Paul Lucha
Journal:  Surg Endosc       Date:  2010-12-08       Impact factor: 4.584

3.  Pneumothorax during laparoscopy.

Authors:  R Ludemann; R Krysztopik; G G Jamieson; D I Watson
Journal:  Surg Endosc       Date:  2003-10-23       Impact factor: 4.584

4.  Post-operative complications and readmissions following outpatient elective Nissen fundoplication.

Authors:  Tarik K Yuce; Ryan J Ellis; Ryan P Merkow; Nathaniel J Soper; Karl Y Bilimoria; David D Odell
Journal:  Surg Endosc       Date:  2019-08-06       Impact factor: 4.584

Review 5.  Endoscopic treatment of gastro-oesophageal reflux disease.

Authors:  M A Bianco; G Rotondano; M L Garofano; L Cipolletta
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-10       Impact factor: 2.124

6.  Indications for the laparoscopic treatment of gastroesophageal reflux disease.

Authors:  Vincenzo Neri; Antonio Ambrosi; Giuseppe Di Lauro; Alberto Fersini; Tiziano Pio Valentino
Journal:  JSLS       Date:  2005 Jan-Mar       Impact factor: 2.172

Review 7.  Surgical reintervention after failed antireflux surgery: a systematic review of the literature.

Authors:  Edgar J B Furnée; Werner A Draaisma; Ivo A M J Broeders; Hein G Gooszen
Journal:  J Gastrointest Surg       Date:  2009-04-04       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.